ReProtect, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm
Phase 2
Completed
- Conditions
- Contraception
- First Posted Date
- 2006-11-09
- Last Posted Date
- 2006-11-09
- Lead Sponsor
- ReProtect Inc
- Target Recruit Count
- 200
- Registration Number
- NCT00397670
News
No news found